CERVOMED ANNOUNCES LAST PATIENT LAST VISIT IN PHASE 2B REWIND-LB TRIAL OF NEFLAMAPIMOD FOR THE TREATMENT OF EARLY-STAGE DEMENTIA WITH LEWY BODIES (DLB)

Reuters · 10/15 12:00

Please log in to view news